Download presentation
Presentation is loading. Please wait.
Published byXavier Wells Modified over 10 years ago
1
Stand der Technik und Visionen am Beispiel der onkologischen Diagnostik
2
Onkologische Diagnostik Pathology as the enabler of human research Crawford und Tykosinski, 2005 Lab Invest
3
Onkologische Diagnostik - Pathologie Cancer classification has been based primarily on morphological appearance Golub et al., 1999 Science
4
Morphologie - Leitmotiv Prof. Dr. Axel Niendorf Singer, Suhrkamp 2002
5
Bronchialkarzinom – Pathologie - Klassifikation - Grading - Typing (WHO) - Staging (UICC)
6
Adenokarzinom – Lunge - Typing Prof. Dr. Axel Niendorf
7
Plattenepithelkarzinom – Lunge - Typing Prof. Dr. Axel Niendorf
8
Kleinzelliges Karzinom – Lunge - Typing Prof. Dr. Axel Niendorf
9
Bronchialkarzinom - Heterogenität –innerhalb einer Gruppe –innerhalb eines Falles: 45% major heterogeneity Roggli et al., 1985 Hum Pathol
10
Prognose – Bronchialkarzinom - Typing Prof. Dr. Axel Niendorf Rhode et al., 2003 Dissertation
11
Prognose – Bronchialkarzinom - Staging Prof. Dr. Axel Niendorf Rhode et al., 2003 Dissertation
12
Bronchialkarzinom - Grading Prof. Dr. Axel Niendorf G IG III
13
Onkologische Diagnostik - Vision - Früherkennung - Stratifizierung (Risk assessment) - individualisierte Therapieempfehlung - Therapiemonitoring
14
Biomarker - Definition - Objektiv messbares Merkmal - Indikator eines biologischen Prozesses
15
Tumor - Eigenschaften Prof. Dr. Axel Niendorf Hanahan et al., 2000 Cell Figure 1. Acquired Capabilities of Cancer We suggest that most if not all cancers have acquired the same set of functional capabilities during their development, albeit through various mechanistic strategies
16
Biomarker - Analytik - RNA - DNA - Protein - funktionell
17
Biomarker – Molekulares Profil Prof. Dr. Axel Niendorf
18
Molekulares Profil – Bronchialkarzinom - Zusammenfassung - bekannte Klassen matchen - neue Klassen definieren - Quelle für neue Biomarker
19
Komplexes Tumorgewebe Prof. Dr. Axel Niendorf Figure 3. Tumors as Complex Tissues The field of cancer research has largely been guided by a reductionist focus on cancer cells and the genes within them (left panel)a focus that has produced an extraordinary body of knowledge. Looking forward in time, we believe that important new inroads will come from regarding tumors as complex tissues in which mutant cancer cells have conscripted and subverted normal cell types to serve as active collaborators in their neoplastic agenda (right panel). The interactions between the genetically altered malignant cells and these supporting coconspirators will prove critical to understanding cancer pathogenesis and to the development of novel, effective therapies. Hanahan et al., 2000 Cell
20
Molekulares Profil - Präparation Prof. Dr. Axel Niendorf
21
Mikrodissektion - Morphologie Prof. Dr. Axel Niendorf
22
Tissue Microarray Prof. Dr. Axel Niendorf Lakhani und Ashworth, 2001 Nature Reviews Cancer
23
Biomarker -Tumordatenbank Prof. Dr. Axel Niendorf Gewebebank Tumordatenbank -autom. Mikroskopie -Bildanalyse -Klinische Metadaten -Genexpressionen -Proteinexpression
24
Tumordatenbank - Metaanalyse Prof. Dr. Axel Niendorf World Knowledge Create novel approaches in diagnostics MEDEEA Pathology Metalife IT Filter & Extract
25
Onkologische Diagnostik - Schlussfolgerung - Material - Verfahren - Analyse
Similar presentations
© 2024 SlidePlayer.com Inc.
All rights reserved.